Suppr超能文献

眼部附属器黏膜相关淋巴组织结外边缘区B细胞淋巴瘤的放射治疗:一项对50例患者的多机构回顾性研究

Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.

作者信息

Uno Takashi, Isobe Koichi, Shikama Naoto, Nishikawa Atsushi, Oguchi Masahiko, Ueno Naoyuki, Itami Jun, Ohnishi Hiroshi, Mikata Atsuo, Ito Hisao

机构信息

Department of Radiology, Chiba University Graduate School of Medicine, Chiba, Japan.

出版信息

Cancer. 2003 Aug 15;98(4):865-71. doi: 10.1002/cncr.11539.

Abstract

BACKGROUND

Due to the small number of patients and differences in the pathologic classification in most radiotherapy series, information regarding the adequacy of tumor control in patients with ocular-adnexal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is limited.

METHODS

A multiinstitutional, retrospective study was performed on 50 patients with Stage IE ocular-adnexal MALT lymphoma who were treated with radiotherapy between 1989 and 1999. The impact of patient characteristics and other variables on tumor control was analyzed.

RESULTS

Responses to radiotherapy include a complete response (CR) in 26 patients, a partial response (PR) in 20 patients, and no change in 4 patients. Forty-nine of 50 patients obtained tumor control in the ocular adnexa at 24 months. Overall, 6 patients exhibited disease recurrence at 4-97 months. Three patients developed recurrence in the ocular adnexa. Two patients had isolated extranodal failure involving the oral floor and the submandibular gland, and one patient experienced failure in the neck lymph node. The initial tumor response had a marginal impact on the development of recurrence. None of the 26 patients who achieved a CR experienced ocular-adnexal recurrence. All three patients who experienced local treatment failure belonged to the initial PR group. In total, five of six patients who developed recurrent disease had obtained a PR after initial radiotherapy. Age, gender, tumor location, and dose of radiotherapy did not influence the development of recurrence. There was only one death due to lymphoma. The 5-year overall survival rate was 91% with a median follow-up of 46 months.

CONCLUSIONS

Radiotherapy offers excellent local control with a prolonged clinical course for patients with MALT lymphoma in the ocular adnexa. The initial response to radiotherapy marginally influenced the probability of recurrence.

摘要

背景

由于大多数放疗系列研究中的患者数量较少且病理分类存在差异,关于黏膜相关淋巴组织边缘区B细胞淋巴瘤(MALT淋巴瘤)累及眼附属器患者的肿瘤控制充分性的信息有限。

方法

对1989年至1999年间接受放疗的50例IE期眼附属器MALT淋巴瘤患者进行了一项多机构回顾性研究。分析了患者特征和其他变量对肿瘤控制的影响。

结果

放疗反应包括26例完全缓解(CR)、20例部分缓解(PR)和4例无变化。50例患者中有49例在24个月时眼附属器获得肿瘤控制。总体而言,6例患者在4至97个月时出现疾病复发。3例患者眼附属器复发。2例患者出现孤立的结外失败,累及口腔底部和颌下腺,1例患者颈部淋巴结出现失败。初始肿瘤反应对复发的发生影响较小。26例达到CR的患者均未出现眼附属器复发。所有3例经历局部治疗失败的患者均属于初始PR组。在总共6例出现复发疾病的患者中,有5例在初始放疗后获得了PR。年龄、性别、肿瘤位置和放疗剂量均未影响复发的发生。仅1例患者死于淋巴瘤。5年总生存率为91%,中位随访时间为46个月。

结论

放疗为眼附属器MALT淋巴瘤患者提供了良好的局部控制,临床病程延长。放疗的初始反应对复发概率影响较小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验